BSI 22/30449644 DC 2022
$24.66
BS EN ISO 23500-1. Preparation and quality management of fluids for haemodialysis and related therapies – Part 1. General requirements
Published By | Publication Date | Number of Pages |
BSI | 2022 | 113 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
7 | Foreword |
8 | Introduction |
9 | 1 Scope 1.1 General 1.2 Inclusions |
10 | 1.3 Exclusions 2 Normative references 3 Terms and definitions |
18 | 4 Quality requirements 4.1 General 4.2 Dialysis water 4.2.1 General 4.2.2 Chemical contaminants in dialysis water |
20 | 4.2.3 Organic Carbon, pesticides and other chemicals |
21 | 4.2.4 Microbiological contaminants in dialysis water 4.3 Requirements for concentrate 4.3.1 Chemical and microbiological contaminants in concentrate 4.3.2 Water used to prepare concentrate |
22 | 4.4 Requirements for dialysis fluid 4.4.1 General 4.4.2 Microbiological requirements for standard dialysis fluid 4.4.3 Microbiological requirements for ultrapure dialysis fluid |
23 | 4.4.4 Microbiological requirements for online-prepared substitution fluid 4.5 Record retention 5 System design and technical considerations 5.1 General |
24 | 5.2 Technical aspects |
25 | 5.3 Microbiological aspects 5.4 Environmental impact |
26 | 6 Validation of system performance 6.1 General |
27 | 6.2 Validation plan 6.3 Installation and operational qualification |
28 | 6.4 Performance qualification |
29 | 6.5 Validation 6.5.1 Initial Validation. 6.5.2 Retrospective [Annual] Validation 6.5.3 Revalidation 6.6 Surveillance |
30 | 7 Quality management 7.1 General 7.2 Surveillance of fluid quality 7.2.1 Surveillance of dialysis water quality |
31 | 7.2.2 Surveillance of concentrate quality 7.2.3 Surveillance of dialysis fluid quality 7.3 Surveillance of water treatment equipment 7.3.1 General 7.3.2 Surveillance of sediment filters 7.3.3 Surveillance of cartridge filters |
32 | 7.3.4 Surveillance of softeners 7.3.5 Surveillance of carbon media |
33 | 7.3.6 Surveillance of chemical injection systems 7.3.7 Surveillance of reverse osmosis |
34 | 7.3.8 Surveillance of deionization |
35 | 7.3.9 Surveillance of endotoxin-retentive filters 7.3.10 Surveillance of water storage tanks 7.3.11 Surveillance of the water distribution systems 7.3.12 Surveillance of bacterial control devices |
36 | 7.4 Surveillance of concentrate preparation 7.4.1 Surveillance of mixing systems 7.4.2 Surveillance of additives |
37 | 7.5 Surveillance of concentrate distribution 7.6 Surveillance of dialysis fluid proportioning 8 Strategies for microbiological control 8.1 General |
38 | 8.2 Disinfection 8.2.1 General 8.2.2 Microbiological aspects of fluid system design |
39 | 8.2.3 Disinfection frequency |
40 | 8.3 Microbiological surveillance methods 8.3.1 General 8.3.2 Sample collection |
41 | 8.3.3 Heterotrophic plate count |
43 | 8.3.4 Bacterial endotoxin test 8.3.5 Determination of yeast and mould |
44 | 9 Location of and access to the water treatment system 10 Personnel |
45 | Annex€A (informative) Rationale for the development and provisions of this document |
51 | Annex€B (informative) Equipment |
71 | Annex€C (informative) Surveillance guidelines for water treatment equipment, distribution€systems, and dialysis fluid |
76 | Annex€D (informative) Strategies for microbiological control |
83 | Annex€E (informative) Validation |
90 | Annex€F (informative) Special considerations for home haemodialysis |
97 | Annex€G (informative) Special considerations for acute haemodialysis |
102 | Annex€H (informative) Further considerations for the different water quality monitoring approaches |
104 | Annex€I (informative) Further considerations for risk assessment |
107 | Bibliography |